Zhen Zhang1, Qifang Bi2, Shisong Fang3, Lan Wei1, Xin Wang3, Jianfan He4, Yongsheng Wu1, Xiaojian Liu1, Wei Gao5, Renli Zhang3, Wenfeng Gong6, Qiru Su7, Andrew S Azman2, Justin Lessler2, Xuan Zou4. 1. Department of Public Health Information, Shenzhen Center for Disease Control and Prevention, Shenzhen, China. 2. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 3. Department of Pathogenic Biology, Shenzhen Center for Disease Control and Prevention, Shenzhen, China. 4. Shenzhen Center for Disease Control and Prevention, Shenzhen, China. 5. Department of Communicable Diseases Control and Prevention, Shenzhen Center for Disease Control and Prevention, Shenzhen, China. 6. The Bill & Melinda Gates Foundation, Seattle, WA, USA. 7. Pediatric Research Institute, Shenzhen Children's Hospital, Shenzhen, China.
Abstract
BACKGROUND: Virological detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through RT-PCR has limitations for surveillance. Serological tests can be an important complementary approach. We aimed to assess the practical performance of RT-PCR-based surveillance protocols and determine the extent of undetected SARS-CoV-2 infection in Shenzhen, China. METHODS: We did a cohort study in Shenzhen, China and attempted to recruit by telephone all RT-PCR-negative close contacts (defined as those who lived in the same residence as, or shared a meal, travelled, or socially interacted with, an index case within 2 days before symptom onset) of all RT-PCR-confirmed cases of SARS-CoV-2 detected since January, 2020, via contact tracing. We measured anti-SARS-CoV-2 antibodies in serum samples from RT-PCR-negative close contacts 2-15 weeks after initial virological testing by RT-PCR, using total antibody, IgG, and IgM ELISAs. In addition, we did a serosurvey of volunteers from neighbourhoods with no reported cases, and from neighbourhoods with reported cases. We assessed rates of infection undetected by RT-PCR, performance of RT-PCR over the course of infection, and characteristics of individuals who were seropositive on total antibody ELISA but RT-PCR negative. FINDINGS: Between April 12 and May 4, 2020, we enrolled and collected serological samples from 2345 (53·0%) of 4422 RT-PCR-negative close contacts of cases of RT-PCR-confirmed SARS-CoV-2. 1175 (50·1%) of 2345 were close contacts of cases diagnosed in Shenzhen with contact tracing details, and of these, 880 (74·9%) had serum samples collected more than 2 weeks after exposure to an index case and were included in our analysis. 40 (4·5%) of 880 RT-PCR-negative close contacts were positive on total antibody ELISA. The seropositivity rate with total antibody ELISA among RT-PCR-negative close contacts, adjusted for assay performance, was 4·1% (95% CI 2·9-5·7), which was significantly higher than among individuals residing in neighbourhoods with no reported cases (0·0% [95% CI 0·0-1·1]). RT-PCR-positive individuals were 8·0 times (95% CI 5·3-12·7) more likely to report symptoms than those who were RT-PCR-negative but seropositive, but both groups had a similar distribution of sex, age, contact frequency, and mode of contact. RT-PCR did not detect 48 (36% [95% CI 28-44]) of 134 infected close contacts, and false-negative rates appeared to be associated with stage of infection. INTERPRETATION: Even rigorous RT-PCR testing protocols might miss a substantial proportion of SARS-CoV-2 infections, perhaps in part due to difficulties in determining the timing of testing in asymptomatic individuals for optimal sensitivity. RT-PCR-based surveillance and control protocols that include rapid contact tracing, universal RT-PCR testing, and mandatory 2-week quarantine were, nevertheless, able to contain community spread in Shenzhen, China. FUNDING: The Bill & Melinda Gates Foundation, Special Foundation of Science and Technology Innovation Strategy of Guangdong Province, and Key Project of Shenzhen Science and Technology Innovation Commission.
BACKGROUND: Virological detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through RT-PCR has limitations for surveillance. Serological tests can be an important complementary approach. We aimed to assess the practical performance of RT-PCR-based surveillance protocols and determine the extent of undetected SARS-CoV-2 infection in Shenzhen, China. METHODS: We did a cohort study in Shenzhen, China and attempted to recruit by telephone all RT-PCR-negative close contacts (defined as those who lived in the same residence as, or shared a meal, travelled, or socially interacted with, an index case within 2 days before symptom onset) of all RT-PCR-confirmed cases of SARS-CoV-2 detected since January, 2020, via contact tracing. We measured anti-SARS-CoV-2 antibodies in serum samples from RT-PCR-negative close contacts 2-15 weeks after initial virological testing by RT-PCR, using total antibody, IgG, and IgM ELISAs. In addition, we did a serosurvey of volunteers from neighbourhoods with no reported cases, and from neighbourhoods with reported cases. We assessed rates of infection undetected by RT-PCR, performance of RT-PCR over the course of infection, and characteristics of individuals who were seropositive on total antibody ELISA but RT-PCR negative. FINDINGS: Between April 12 and May 4, 2020, we enrolled and collected serological samples from 2345 (53·0%) of 4422 RT-PCR-negative close contacts of cases of RT-PCR-confirmed SARS-CoV-2. 1175 (50·1%) of 2345 were close contacts of cases diagnosed in Shenzhen with contact tracing details, and of these, 880 (74·9%) had serum samples collected more than 2 weeks after exposure to an index case and were included in our analysis. 40 (4·5%) of 880 RT-PCR-negative close contacts were positive on total antibody ELISA. The seropositivity rate with total antibody ELISA among RT-PCR-negative close contacts, adjusted for assay performance, was 4·1% (95% CI 2·9-5·7), which was significantly higher than among individuals residing in neighbourhoods with no reported cases (0·0% [95% CI 0·0-1·1]). RT-PCR-positive individuals were 8·0 times (95% CI 5·3-12·7) more likely to report symptoms than those who were RT-PCR-negative but seropositive, but both groups had a similar distribution of sex, age, contact frequency, and mode of contact. RT-PCR did not detect 48 (36% [95% CI 28-44]) of 134 infected close contacts, and false-negative rates appeared to be associated with stage of infection. INTERPRETATION: Even rigorous RT-PCR testing protocols might miss a substantial proportion of SARS-CoV-2 infections, perhaps in part due to difficulties in determining the timing of testing in asymptomatic individuals for optimal sensitivity. RT-PCR-based surveillance and control protocols that include rapid contact tracing, universal RT-PCR testing, and mandatory 2-week quarantine were, nevertheless, able to contain community spread in Shenzhen, China. FUNDING: The Bill & Melinda Gates Foundation, Special Foundation of Science and Technology Innovation Strategy of Guangdong Province, and Key Project of Shenzhen Science and Technology Innovation Commission.
Authors: Rita Christiane Baron; Lorenz Risch; Myriam Weber; Sarah Thiel; Kirsten Grossmann; Nadia Wohlwend; Thomas Lung; Dorothea Hillmann; Michael Ritzler; Susanna Bigler; Konrad Egli; Francesca Ferrara; Thomas Bodmer; Mauro Imperiali; Sonja Heer; Harald Renz; Lukas Flatz; Philipp Kohler; Pietro Vernazza; Christian R Kahlert; Matthias Paprotny; Martin Risch Journal: Clin Chem Lab Med Date: 2020-08-31 Impact factor: 3.694
Authors: Juliet E Bryant; Andrew S Azman; Matthew J Ferrari; Benjamin F Arnold; Maciej F Boni; Yap Boum; Kyla Hayford; Francisco J Luquero; Michael J Mina; Isabel Rodriguez-Barraquer; Joseph T Wu; Djibril Wade; Guy Vernet; Daniel T Leung Journal: Sci Immunol Date: 2020-05-19
Authors: Anita S Iyer; Forrest K Jones; Ariana Nodoushani; Jason B Harris; Richelle C Charles; Meagan Kelly; Margaret Becker; Damien Slater; Rachel Mills; Erica Teng; Mohammad Kamruzzaman; Wilfredo F Garcia-Beltran; Michael Astudillo; Diane Yang; Tyler E Miller; Elizabeth Oliver; Stephanie Fischinger; Caroline Atyeo; A John Iafrate; Stephen B Calderwood; Stephen A Lauer; Jingyou Yu; Zhenfeng Li; Jared Feldman; Blake M Hauser; Timothy M Caradonna; John A Branda; Sarah E Turbett; Regina C LaRocque; Guillaume Mellon; Dan H Barouch; Aaron G Schmidt; Andrew S Azman; Galit Alter; Edward T Ryan Journal: Sci Immunol Date: 2020-10-08
Authors: Ingrid Arevalo-Rodriguez; Diana Buitrago-Garcia; Daniel Simancas-Racines; Paula Zambrano-Achig; Rosa Del Campo; Agustin Ciapponi; Omar Sued; Laura Martinez-García; Anne W Rutjes; Nicola Low; Patrick M Bossuyt; Jose A Perez-Molina; Javier Zamora Journal: PLoS One Date: 2020-12-10 Impact factor: 3.240
Authors: Bas Kolen; Laurens Znidarsic; Andreas Voss; Simon Donders; Iris Kamphorst; Maarten van Rijn; Dimitri Bonthuis; Merit Clocquet; Maarten Schram; Rutger Scharloo; Tim Boersma; Tim Stobernack; Pieter van Gelder Journal: Int J Environ Res Public Health Date: 2022-06-13 Impact factor: 4.614
Authors: Hannah L Itell; Haidyn Weight; Carolyn S Fish; Jennifer K Logue; Nicholas Franko; Caitlin R Wolf; Denise J McCulloch; Jared Galloway; Frederick A Matsen; Helen Y Chu; Julie Overbaugh Journal: Microbiol Spectr Date: 2021-10-20
Authors: Justin Lessler; Andrew S Azman; Qifang Bi; Isabella Eckerle; Stephen A Lauer; Laurent Kaiser; Nicolas Vuilleumier; Derek A T Cummings; Antoine Flahault; Dusan Petrovic; Idris Guessous; Silvia Stringhini Journal: Nat Commun Date: 2021-06-15 Impact factor: 17.694
Authors: Zuzana Dankova; Elena Novakova; Maria Skerenova; Veronika Holubekova; Vincent Lucansky; Dana Dvorska; Dusan Brany; Zuzana Kolkova; Jan Strnadel; Sandra Mersakova; Katarina Janikova; Marek Samec; Michal Pokusa; Martin Petras; Miroslava Sarlinova; Ivana Kasubova; Dusan Loderer; Vladimira Sadlonova; Jana Kompanikova; Nina Kotlebova; Adriana Kompanikova; Martina Hrnciarova; Andrea Stanclova; Martina Antosova; Anton Dzian; Vladimir Nosal; Ivan Kocan; Dalibor Murgas; Dusan Krkoska; Andrea Calkovska; Erika Halasova Journal: Int J Environ Res Public Health Date: 2021-07-01 Impact factor: 3.390
Authors: Luísa Canto E Castro; Andreia Gomes; Marta Serrano; Ana Helena Guia Pereira; Rita Ribeiro; Patrícia Napoleão; Inês Domingues; Cláudia Silva; Júlia Fanczal; Ângela Afonso; Andreia Lopes; Ionela Toader; Maria José Rego de Sousa; José Germano Rego de Sousa; Germano de Sousa; Maria M Mota; Bruno Silva-Santos; Marc Veldhoen; Ruy M Ribeiro Journal: Eur J Immunol Date: 2021-11-10 Impact factor: 6.688